Lundbeck Is Said to Express Interest in Xeris Biopharma

H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, people familiar with the matter said. The potential deal would mark a significant move in the pharmaceutical sector, as Lundbeck seeks to expand its portfolio. No financial terms were disclosed, and talks may not lead to an agreement.